These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 33996914)

  • 1.
    Hashemi ZS; Zarei M; Fath MK; Ganji M; Farahani MS; Afsharnouri F; Pourzardosht N; Khalesi B; Jahangiri A; Rahbar MR; Khalili S
    Front Mol Biosci; 2021; 8():669431. PubMed ID: 33996914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interfering peptides targeting protein-protein interactions: the next generation of drugs?
    Bruzzoni-Giovanelli H; Alezra V; Wolff N; Dong CZ; Tuffery P; Rebollo A
    Drug Discov Today; 2018 Feb; 23(2):272-285. PubMed ID: 29097277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and Modeling of Protein-Protein Interactions Using "Spotted" Peptides with a Template-Based Approach.
    Gasbarri C; Rosignoli S; Janson G; Boi D; Paiardini A
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Des3PI: a fragment-based approach to design cyclic peptides targeting protein-protein interactions.
    Delaunay M; Ha-Duong T
    J Comput Aided Mol Des; 2022 Aug; 36(8):605-621. PubMed ID: 35932404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive peptidomimetic libraries targeting protein-protein interactions.
    Whitby LR; Boger DL
    Acc Chem Res; 2012 Oct; 45(10):1698-709. PubMed ID: 22799570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational approaches for the design of modulators targeting protein-protein interactions.
    Rehman AU; Khurshid B; Ali Y; Rasheed S; Wadood A; Ng HL; Chen HF; Wei Z; Luo R; Zhang J
    Expert Opin Drug Discov; 2023 Mar; 18(3):315-333. PubMed ID: 36715303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools.
    Vincenzi M; Mercurio FA; Leone M
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational tools for exploring peptide-membrane interactions in gram-positive bacteria.
    Kumar S; Balaya RDA; Kanekar S; Raju R; Prasad TSK; Kandasamy RK
    Comput Struct Biotechnol J; 2023; 21():1995-2008. PubMed ID: 36950221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilized cyclic peptides as modulators of protein-protein interactions: promising strategies and biological evaluation.
    Cheng J; Zhou J; Kong L; Wang H; Zhang Y; Wang X; Liu G; Chu Q
    RSC Med Chem; 2023 Dec; 14(12):2496-2508. PubMed ID: 38107173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the performance of MM/PBSA and MM/GBSA methods. 9. Prediction reliability of binding affinities and binding poses for protein-peptide complexes.
    Weng G; Wang E; Chen F; Sun H; Wang Z; Hou T
    Phys Chem Chem Phys; 2019 May; 21(19):10135-10145. PubMed ID: 31062799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved prediction of protein-protein interactions by a modified strategy using three conventional docking software in combination.
    Choi S; Son SH; Kim MY; Na I; Uversky VN; Kim CG
    Int J Biol Macromol; 2023 Dec; 252():126526. PubMed ID: 37633550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery.
    Trisciuzzi D; Villoutreix BO; Siragusa L; Baroni M; Cruciani G; Nicolotti O
    Expert Opin Drug Discov; 2023 Jul; 18(7):737-752. PubMed ID: 37246811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic and Macrocyclic Peptides as Chemical Tools To Recognise Protein Surfaces and Probe Protein-Protein Interactions.
    Cardote TA; Ciulli A
    ChemMedChem; 2016 Apr; 11(8):787-94. PubMed ID: 26563831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.
    Sugaya N; Ikeda K; Tashiro T; Takeda S; Otomo J; Ishida Y; Shiratori A; Toyoda A; Noguchi H; Takeda T; Kuhara S; Sakaki Y; Iwayanagi T
    BMC Pharmacol; 2007 Aug; 7():10. PubMed ID: 17705877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.
    Sheng C; Dong G; Miao Z; Zhang W; Wang W
    Chem Soc Rev; 2015 Nov; 44(22):8238-59. PubMed ID: 26248294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational approaches to developing short cyclic peptide modulators of protein-protein interactions.
    Duffy FJ; Devocelle M; Shields DC
    Methods Mol Biol; 2015; 1268():241-71. PubMed ID: 25555728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the MreB-CbtA Interaction to Facilitate the Prediction and Design of Candidate Antibacterial Peptides.
    Awuni E
    Front Mol Biosci; 2021; 8():814935. PubMed ID: 35155572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of in Silico Methods for Design and Development of Drugs Targeting Protein-Protein Interactions.
    Cicaloni V; Trezza A; Pettini F; Spiga O
    Curr Top Med Chem; 2019; 19(7):534-554. PubMed ID: 30836920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.